cdc rsv - Search News

Order byBest matchMost fresh

CDC official overseeing COVID hospitalization data resigns

US CDC official in charge of COVID, RSV data resigns ahead of vaccine meeting

A U.S. government scientist who oversees the team responsible for collecting data on COVID-19 and RSV hospitalizations used to shape national vaccine policy has resigned, citing concerns over how such data would be used by the Trump administration.

· 5h · on MSN

CDC official overseeing COVID hospitalization data resigns in protest

· 9h · on MSN

CDC virus expert resigns after RFK Jr.’s purge of vaccine advisers

· 1d

How one meeting in 2020 and a GOP senator helped create RFK Jr.’s vaccine wreck

Liberal ideology and Republican politics laid groundwork for Kennedy’s remaking of the CDC’s vaccine panel.

· 13h

Who Is on RFK, Jr.’s New Vaccine Panel—And What Will They Do?

· 1d

RFK Jr.’s mass firing of vaccine advisory panel misses the mark

· 12h

RFK Jr. is wrong. Dismissing vaccine experts won't make us healthier | Opinion

As pediatricians, we have seen patients die from vaccine-preventable diseases.

WNCT · 16h

RFK Jr.’s vaccine moves raise fears ahead of next school year

· 1d

How Kennedy’s overhaul could make vaccines more expensive

4hon MSN

Covid-19 and RSV head data scientist dramatically quits saying she doesn’t trust RFK Jr department to use it ‘objectively’

Covid-19 and RSV head data scientist dramatically quits saying she doesn’t trust RFK Jr department to use it ‘objectively’ - Fiona Havers had worked for the Centers of Disease Control for 13 years bef

Devdiscourse4h

CDC Scientist Resigns Over Concerns of Data Misuse

Dr. Fiona Havers, a U.S. government scientist overseeing COVID-19 and RSV data, resigned, citing concerns over misuse of data by the Trump administration. Following Health Secretary Robert Kennedy Jr.

3don MSN

Moderna falls on doubts over new CDC panel's backing of RSV vaccine

Moderna's shares fell 2.3% on Friday on concerns about whether a new CDC advisory panel would back the use of the company's respiratory syncytial virus vaccine in a broader age group. The mRNA-based RSV shot,

3don MSN

FDA expands approval of Moderna's RSV vaccine to some adults under age 60

The FDA expanded its approval of Moderna's RSV vaccine on Thursday to include adults under age 60 at increased risk of the disease.

Zacks Investment Research on MSN12h

EMA Accepts GSK's Filing for Expanded Use of RSV Vaccine Arexvy

GSK plc GSK announced that the European Medicines Agency (EMA) has accepted the regulatory application seeking approval to expand the use of its adjuvanted recombinant respiratory syncytial virus (RSV) vaccine,

Explore more

COVID

Centers for Disease Control and Prevention

4don MSN

US FDA approves expanded use of Moderna's RSV vaccine for at-risk adults

The U.S. Food and Drug Administration on Thursday expanded the use of Moderna's respiratory syncytial virus vaccine to a lower group of adults aged 18 to 59 years at increased risk for disease. Moderna's RSV shot,

5don MSN

Newly approved antibody could offer another option for protecting infants from RSV, a common infection that can be deadly

The United States could soon have another tool in the fight against respiratory syncytial virus, an illness that’s the No. 1 cause of hospitalization in infants.